Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
15
Active since
1984
Affiliations
New Frontier(Current)
GlaxoSmithKline (United States)
R. A. DAINES is an author at New Frontier specializing in natural sciences, pharmacology, and biochemistry.
Top concepts
PharmacologyNatural SciencesBiochemistryBioorganic ChemistryChemistryOrganic ChemistryMedicineEngineeringMedicinal ChemistryBiosynthesis
Publications per year
1984–2005
Total synthesis of amphotericin B. 3. The final stages
K. C. Nicolaou, R. A. DAINES, Yoshihiro Ogawa et al. · Journal of the American Chemical Society · 1988 · 154 citations
Medicinal Chemistry, Bioorganic Chemistry, Chemical Analysis +13
Total synthesis of amphoteronolide B and amphotericin B. 1. Strategy and stereocontrolled construction of key building blocks
K. C. Nicolaou, R. A. DAINES, J. Uenishi et al. · Journal of the American Chemical Society · 1988 · 121 citations
Key Building Blocks, Bioorganic Chemistry, Engineering +14
Total synthesis of amphoteronolide B and amphotericin B. 2. Total synthesis of amphoteronolide B
K. C. Nicolaou, R. A. DAINES, Tushar Kanti Chakraborty et al. · Journal of the American Chemical Society · 1988 · 113 citations
Bioorganic Chemistry, Engineering, Organic Chemistry +16
Crystal structure and substrate specificity of the β‐ketoacyl‐acyl carrier protein synthase III (FabH) from <i>Staphylococcus aureus</i>
Xiayang Qiu, Anthony E. Choudhry, Cheryl A. Janson et al. · Protein Science · 2005 · 99 citations · Full text
Identification, Substrate Specificity, and Inhibition of theStreptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH)
Sanjay S. Khandekar, Daniel R. Gentry, Glenn S. Van Aller et al. · Journal of Biological Chemistry · 2001 · 98 citations · Full text
1–5 of 19